Diet-induced weight loss is associated with decreases in plasma serum amyloid A and C-reactive protein independent of dietary macronutrient composition in obese subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 4, 2005, Pages 2244-2249

  O'Brien, Kevin D ^a,d   Brehm, Bonnie J ^c   Seeley, Randy J ^b   Bean, Judy ^c   Wener, Mark H ^a   Daniels, Stephen ^c   D'Alessio, David A ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LIPID; SERUM AMYLOID A;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; FEMALE; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LOW FAT DIET; MACRONUTRIENT; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

BLOOD PRESSURE; C-REACTIVE PROTEIN; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; OBESITY; SERUM AMYLOID A PROTEIN; WEIGHT LOSS;

EID: 17844366564     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1011     Document Type: Article

References (33)

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP 2001 The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195-1200
2. Nelson DE, Bland S, Powell-Griner E, Klein R, Wells HE, Hogelin G, Marks JS 2002 State trends in health risk factors and receipt of clinical preventive services among U.S. adults during the 1990s. JAMA 287:2659-2667
3. Flegal KM, Carroll MD, Ogden CL, Johnson CL 2002 Prevalence and trends in obesity among U.S. adults, 1999-2000. JAMA 288:1723-1727
4. Ogden CL, Flegal KM, Carroll MD, Johnson CL 2002 Prevalence and trends in overweight among U.S. children and adolescents, 1999-2000. JAMA 288:1728-1732
5. Atkins RC 1972 Dr. Atkins' diet revolution: the high calorie way to stay thin forever. New York: David McKay, Inc.
6. 1973 A critique of low-carbohydrate ketogenic weight reduction regimens. A review of Dr. Atkins' diet revolution. JAMA 224:1415-1419
7. Anderson JW, Konz EC, Jenkins DJ 2000 Health advantages and disadvantages of weight-reducing diets: a computer analysis and critical review. J Am Coll Nutr 19:578-590
8. Hak AE, Stehouwer CD, Bots ML, Polderman KH, Schalkwijk CG, Westendorp IC, Hofman A, Witteman JC 1999 Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 19:1986-1991
9. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW 1999 C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978
10. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB 1999 Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131-2135
11. van Dielen FM, van't Veer C, Buurman WA, Greve JW 2002 Leptin and soluble leptin receptor levels in obese and weight-losing individuals. J Clin Endocrinol Metab 87:1708-1716
12. Heilbronn LK, Noakes M, Clifton PM 2001 Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 21:968-970
13. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET 2002 Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105:564-569
14. McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, Reaven P 2002 Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106:2908-2912
15. Kisilevsky R, Subrahmanyan L 1992 Serum amyloid A changes high density lipoprotein's cellular, affinity. A clue to serum amyloid A's principal function. Lab Invest [Erratum (1992) 67:151] 66:778-785
16. Malle E, De Beer FC 1996 Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 26:427-435
17. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ 1993 Genetic control of inflammatory gene induction and NF-κB-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91:2572-2579
18. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E 1998 Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 98:839-844
19. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, Sharaf B, Merz CNB, Sopko G, Olson MB, Reis SE 2004 Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women - the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109:726-732
20. Ridker PM, Hennekens CH, Buring JE, Rifai N 2000 C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843
21. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR 2002 Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557-1565
22. Ridker PM, Buring JE, Cook NR, Rifai N 2003 C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 107:391-397
23. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V 2004 C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397
24. Brehm BJ, Seeley RJ, Daniels SR, D'Alessio DA 2003 A randomized trial comparing the effects of a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab 88:1617-1623
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
26. Wallace TM, Matthews DR 2002 The assessment of insulin resistance in man. Diabet Med 19:527-534
27. Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, Brinckerhoff CE, Sukhova GK, Libby P 1998 Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 97:2433-2444
28. Knopp RH, Retzlaff B, Fish B, Walden C, Wallick S, Anderson M, Aikawa K, Kahn SE 2003 Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding. Arterioscler Thromb Vasc Biol 23:1437-1443
29. Davison S, Davis SR 2003 New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 88:2470-2478
30. Abbas A, Fadel PJ, Wang Z, Arbique D, Jialal I, Vongpatanasin W 2004 Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women. Arterioscler Thromb Vasc Biol 24:E164-E167
31. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R 2002 Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903-1913
32. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Aunola S, Cepaitis Z, Moltchanov V, Hakumaki M, Mannelin M, Martikkala V, Sundvall J 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350
33. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403